Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PleurX vs LVP for Diuretic Resistant Ascites
NCT03027635Terminated
- Start
- Jan 2017
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms). Primary endpoint: Time to first paracentesis at 18 months. Started Jan 2017; status: terminated.
Beyond the preview
Go deeper on NCT03027635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027635.